EFEarnings Feed

A

Company dossier

Astex Pharmaceuticals, Inc

CIK 0000919722SIC 2834Pharmaceutical Preparations

Add to watchlist

Exchange

—

Entity type

operating

Fiscal year end

Dec 31

Headquarters

DE

SEC profile ↗

Recent filings

Latest submissions

10 items

8-KAccepted Dec 22, 7:00 PM ETAcc 0000912057-99-010537
SUPERGEN INC9.6 KB
SUPERGEN INC 8-K
View filing
10-QAccepted Nov 14, 7:00 PM ETAcc 0000912057-99-005959
SUPERGEN INC181.4 KB
SUPERGEN INC 10-Q
View filing
8-KAccepted Oct 3, 8:00 PM ETAcc 0001047469-99-037633
SUPERGEN INC7.7 KB
SUPERGEN INC 8-K
View filing
8-KAccepted Aug 25, 8:00 PM ETAcc 0001047469-99-033824
SUPERGEN INC129.5 KB
SUPERGEN INC 8-K
View filing
10-QAccepted Aug 12, 8:00 PM ETAcc 0001047469-99-031971
SUPERGEN INC60.9 KB
SUPERGEN INC 10-Q
View filing
10-QAccepted May 13, 8:00 PM ETAcc 0001047469-99-020659
SUPERGEN INC54.9 KB
SUPERGEN INC 10-Q
View filing
10-KAccepted Mar 30, 7:00 PM ETAcc 0001047469-99-012792
SUPERGEN INC615.7 KB
SUPERGEN INC 10-K
View filing
8-KAccepted Jan 27, 7:00 PM ETAcc 0001047469-99-002496
SUPERGEN INC155.0 KB
SUPERGEN INC 8-K
View filing
10-QAccepted Nov 11, 7:00 PM ETAcc 0001047469-98-040226
SUPERGEN INC64.2 KB
SUPERGEN INC 10-Q
View filing
10-QAccepted Aug 6, 8:00 PM ETAcc 0001047469-98-029937
SUPERGEN INC59.5 KB
SUPERGEN INC 10-Q
View filing

Monitoring

Insider owner filings: No
Insider issuer filings: Yes
Tickers on record: 0

Ticker roster

No tickers on record.

Addresses

business
4140 DUBLIN BLVD SUITE 200
DUBLIN, CA, 94568
mailing
4140 DUBLIN BLVD STE 200
DUBLIN, CA, 94568

Former names

SUPERGEN INC
1996-10-15 – 2011-08-09